Bill > A06927

This bill modifies existing education and public health laws to allow prescription labels for certain medications related to gender dysphoria treatment to include the name or address of the dispensing or prescribing healthcare practice instead of the individual dispenser or prescriber's name. Specifically, the bill applies to medications such as gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, and hormone replacement therapy drugs. The bill requires that when a healthcare prescriber chooses to use the practice name on the prescription label, they must inform the patient of this change. This modification provides healthcare practices with more flexibility in how they label prescriptions while ensuring patient transparency about the labeling approach. The bill would take effect immediately upon passage, potentially offering healthcare providers an alternative method of prescription labeling that may help maintain patient privacy or streamline administrative processes.

Education

https://www.nysenate.gov/legislation/bills/2025/A6927